中文| English
Home
About
Company Introduction
Vision and Mission
Subsidiary enterprises
Contact Us
Ability
Core business
Brand Story
Core Advantages
Blog
Company News
Investor Relations
Sustainable
Our Commitment
Our goal
Our actions
Social honor
Social Responsibility Report
Cultural Heritage
Tibetan medical knowledge
File Download
Technological innovation
Evidence-based medicine
Care for Health
Consumer Q&A
Tibetan medical consultation
Human development
Why choose us?
Industry Standards
Training and Development
Employee Highlights
About Us
Company Profile
Affiliated companies
Qizheng Tibetan Medicine Releases Preliminary Report on First-Half Performance: Operating Profit Up 13.69% Year-on-Year
2025-07-29
New Edition of the Package Insert for Baijie Wan (0.8g per 4 tablets) – Notice of Release
2025-07-10
Announcement of the Release of the New Version of the Instruction Manual for Renqing Mangjue Capsules
2025-06-30
Qizheng Tibetan Medicine Ranks 26th on China’s List of Pharmaceutical R&D Strengths, Leading the Way in Modernization and Innovation of Tibetan Medicine.
2025-06-26
Qizheng Tibetan Medicine: Receives Clinical Approval for a Class 1 New Traditional Chinese Medicine Product
2025-05-31
Qizheng Tibetan Medicine has been awarded the honorary title of “National Civilized Unit.”
2025-05-30
Qizheng Tibetan Medicine: Awarded the Title of “National Advanced Collective in the Industrial and Information Technology System”
2025-04-30
Qizheng Tibetan Medicine Achieves Record-Breaking Performance in 2024; Consistent and Stable Dividends Highlight Strong Growth Momentum.
2025-04-26
Qizheng Tibetan Medicine Releases 2024 ESG Report: A Green and Sustainable Supply Chain Safeguards the Future of the Industry
Qizheng Tibetan Medicine’s 2024 financial report shines: Both revenue and net profit excluding non-recurring items grew at double-digit rates, and its multi-product, omni-channel marketing strategy has yielded remarkable results.